-The Times of India MUMBAI: Here's why drug-resistant tuberculosis (TB) breeds freely in Mumbai: Patients don't get appropriate medication. A new study collating information from eight hospitals and treatment centres across Mumbai, Thane and Navi Mumbai found patients were given drugs that they were resistant to. The study, published in PLOS ONE medical journal recently, looked at 340 patients suffering from multi-drug resistant (MDR) TB between 2005 and 2013. "We found only 29.4% of...
More »SEARCH RESULT
Total Matching Records found : 140
Govt to sell 504 drugs under 'Jan Aushadhi' -Sushmi Dey
-The Times of India NEW DELHI: From July 1, you can walk up to a chemist and ask for a 'Jan Aushadhi' brand for your medicine, with the government set to launch its own brand to sell low cost generic medicines. The Centre will procure medicines in bulk from public as well as private drug manufacturing firms and rebrand them under 'Jan Aushadhi'. These will be sold in the retail market at...
More »Is Swachhata only about litter? -Ruhi Saith
-The Hindu The programme needs to retain the momentum of a movement than that of a litter-cleaning project "Slum districts... consisted of poorly built houses, a deficiency of ventilation and toilets, unpaved narrow streets, mud, and stomach-turning stenches due to the presence of decaying refuse and sewerage. In such conditions, ill health was observably endemic." This is not a description of Indian cities today (though it may well be), but of Britain around...
More »52 more drugs brought under price ceiling
-Business Standard This would be in addition to 348 drugs already under price ceiling The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck. This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are Antibiotics, painkillers and medicines used for treating cancer and skin...
More »Why do Indian health authorities keep quiet on pharma firms' failings? -Nivedita Mookerji
-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...
More »
